Health Care & Life Sciences » Biotechnology | Spark Therapeutics Inc.

Spark Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
633.90
22,063.70
20,182.80
12,065.60
64,725
SG&A Expense
7,277.80
24,044.50
67,648.50
130,515.40
241,422.90
243,231
EBIT
7,277.80
23,580.30
47,317.80
113,966.90
234,217.70
193,339
Unusual Expense
50,000.00
750.00
-
11,432.10
24,300.30
5,378
Interest Expense
-
-
-
14.50
48.00
734
Pretax Income
57,277.80
24,324.80
47,125.80
123,652.50
254,445.00
78,723
Income Tax
-
-
-
-
963.00
99
Consolidated Net Income
57,277.80
24,324.80
47,125.80
123,652.50
253,482.00
78,822
Net Income
57,277.80
24,324.80
47,125.80
123,652.50
253,482.00
78,822
Net Income After Extraordinaries
57,277.80
24,324.80
47,125.80
123,652.50
253,482.00
78,822
Net Income Available to Common
57,277.80
25,032.20
47,760.60
123,652.50
253,482.00
78,822
EPS (Basic)
2.33
1.02
2.10
4.29
7.63
2.11
Basic Shares Outstanding
24,540.40
24,540.40
22,710.10
28,804.10
33,242.10
37,366.80
EPS (Diluted)
2.33
1.02
2.10
4.29
7.63
2.11
Diluted Shares Outstanding
24,540.40
24,540.40
22,710.10
28,804.10
33,242.10
37,366.80
EBITDA
-
23,410.50
45,584.80
110,332.50
229,357.20
186,421
Non-Operating Interest Income
-
5.50
192.00
1,761.00
4,120.90
10,728
Preferred Dividends
-
707.30
634.80
-
-
-

About Spark Therapeutics

View Profile
Address
3737 Market Street
Philadelphia Pennsylvania 19104
United States
Employees -
Website http://www.sparktx.com
Updated 07/08/2019
Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.